Bibliographic Details
Title: |
miR-876-5p suppresses breast cancer progression through targeting TFAP2A. |
Authors: |
Xu, Jie, Zheng, Jie, Wang, Jian, Shao, Jianping |
Source: |
Experimental & Therapeutic Medicine; Aug2019, Vol. 18 Issue 2, p1458-1464, 7p |
Subject Terms: |
BREAST cancer, CANCER invasiveness, CANCER cell migration, CANCER cell proliferation, MICRORNA |
Abstract: |
MicroRNAs (miRNAs) are widely expressed in human cells and closely associated with various types of cancer, including breast cancer. miR-876-5p has been indicated to participate in the tumorigenesis of certain types of cancer, such as hepatocellular carcinoma. Nevertheless, the roles of miR-876-5p in breast cancer remain unclear. In the present study, it was revealed that miR-876-5p expression levels were decreased in breast cancer cells compared with a normal cell line. miR-876-5p ectopic expression suppressed breast cancer cell proliferation and arrested progression of the cell cycle. In addition, miR-876-5p suppressed breast cancer cell migration and invasion. miR-876-5p was demonstrated to directly target transcription factor AP-2-α (TFAP2A) in breast cancer cells, and restoration of TFAP2A rescinded the suppressive role of miR-876-5p. In summary, the results from the present study provide evidence that miR-876-5p suppresses breast cancer progression by regulating cell proliferation, migration and invasion in a TFAP2A-dependent manner. [ABSTRACT FROM AUTHOR] |
|
Copyright of Experimental & Therapeutic Medicine is the property of Spandidos Publications UK Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |
Full text is not displayed to guests. |
Login for full access.
|